Search Videos and More
News
Leading From the Lab: Basic Science Advancements of Clinical Consequence
The breadth and richness of basic science research underway at Cedars-Sinai Cancer has wide-ranging implications that alter the approach to cancer care—and future research—here and around the world.
News
Addressing Community-Level Needs Using World-Class Methods
When Dan Theodorescu, MD, PhD, director of Cedars-Sinai Cancer, joined Cedars-Sinai in 2018, he launched a multimillion-dollar initiative to grow the size, reputation and impact of the center.
News
Faculty Publications Jan. 4-11
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Jan. 4-11.
News
Faculty Publications Dec. 7-14
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Dec. 7-14.
News
Faculty Publications Nov. 30-Dec. 7
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Nov. 30-Dec. 7.
News
Lower Back Pain Linked to Subtype of Cells in Spinal “Shock Absorbers"
A new Cedars-Sinai study might have cracked the mystery surrounding the cause of a specific type of back pain.
News
Faculty Publications Nov. 16-30
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Nov. 16-30.
News
Faculty Publications Nov. 9-16
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Nov. 9-16.
News
A Stent—And No Stroke—For This Patient
Cedars-Sinai Neurosurgeons Use Minimally Invasive, State-of-the-Art Stenting to Restore Blood Flow to the Brain, Preventing a Debilitating Stroke
News
Treating Pituitary Apoplexy: Medical Management Versus Surgery
Multicenter International Study, Led by Cedars-Sinai, Finds Medical Management Yields Similar Results to Surgery
News
Faculty Publications Nov. 2-9
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Oct. Nov. 2-9.
News
Cedars-Sinai Neurology Chair Honored by National MS Society for COVID-19 Work
Early in the pandemic, patients with multiple sclerosis (MS), an autoimmune disease, were thought to possibly be at higher-than-average risk for COVID-19.